Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
07 November 2014 09:36
Researchers have developed a new drug for asthma patients
Researchers have developed a drug that offers new hope to those suffering from asthma or chronic obstructive pulmonary disease (COPD).
The new medicine, called RPL554, works by blocking two enzymes in the body and can help to relax the airway muscles as well as reducing inflammation in sufferers.
Experts say the drug could revolutionise the treatment of asthma and COPD as it does not have any of the substantial side effects of current treatments.
A new treatment with minimal side-effects could encourage asthma sufferers to travel more - however before doing so they should be sure to arrange asthma travel insurance.
A trial carried out across three countries - the UK, the Netherlands and Italy - found that RPL554 relieves patients of symptoms and also has an an ti-inflammatory effect.
After a week of treatment, COPD patients were able to forcibly exhale a 17% higher volume of air after breathing in deeply than before.
The researchers said participants in the trial - both the placebo group and sufferers - had a good tolerance of the drug, and only mild side effects were noted.
RPL554 treatment also did not cause any of the stomach issues linked to current asthma and COPD drugs.
Treatments for these conditions have remained largely the same for the past four decades, although experts started to doubt their effectiveness after they were found to worsen asthma symptoms and fail to protect from flare ups.
What the experts at Asthma UK say
Dr Samantha Walker, director of research and policy at Asthma UK, described the new drug as "unique" because it has two effects at the same time.
She said the 250,000 people in the UK with severe asthma urgently need better medication, adding that current treatments come with a range of "unwelcome side effects" such as osteoporosis, sleep problems, weight gain and depression.
Asthma UK will watch the development of RPL554 "with great interest", Dr Walker said.
The findings of the study have been published in the journal The Lancet Respiratory Medicine.
16 February 2019
Holidaymakers were left fuming after a "lack of clarity" over Brexit led a Romanian airline to cancel flights from Liverpool's John Lennon Airport.
[more...]
15 February 2019
British Airways celebrated Valentine's Day with a special flight where all members of the cabin crew were couples who work for the airline.
14 February 2019
The "concerning" level of stigma surrounding the human papilloma virus (HPV) could be putting some women off going for vital check-ups, campaigners are warning.
13 February 2019
Older people living with depression should be given better access to community activities and therapy instead of being prescribed antidepressants, researchers have urged.
12 February 2019
The Government has been criticised for failing to act on warnings about the link between processed meats and cancer, by the scientist who co-authored the original advice.
09 February 2019
A grandfather who has battled three types of cancer is cycling from Twickenham to Tokyo in time for the Rugby World Cup - all in aid of charity.
08 February 2019
Lovers of traditional fish and chips are embracing a more health-conscious version of their favourite food, a new study suggests.
07 February 2019
Two thirds of UK adults don't know they're able to lower their risk of developing dementia, new research has shown.
06 February 2019
More than 600 people a day are quitting their jobs to care for relatives, a charity has warned.
05 February 2019
Millennials in the US face an increasing risk of developing an obesity-related cancer, a new study has revealed.
02 February 2019
More than 100 people sought refuge at a pub high on Bodmin Moor overnight after heavy snowfall hit the A30, leading many stranded motorists to abandon their cars.
01 February 2019
Smokers are almost twice as likely to quit with the help of e-cigarettes than if they rely on nicotine patches or gum, a study has found.